ID   KSCBi002-A
AC   CVCL_IT63
SY   hFSiPS1
DR   BioSamples; SAMEA104012352
DR   hPSCreg; KSCBi002-A
DR   SKIP; SKIP002915
DR   Wikidata; Q54900498
RX   PubMed=28677527;
RX   PubMed=31841972;
RX   PubMed=33714852;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28677527
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 30,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT64 ! KSCBi002-B
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
RX   PubMed=28677527; DOI=10.1016/j.scr.2017.03.009;
RA   Uhm K.-O., Kim S.-J., Jo E.H., Go G.Y., Choi H.Y., Im Y.S., Ha H.-Y.,
RA   Kim J.-H., Koo S.K.;
RT   "Generation of human induced pluripotent stem cell lines from human
RT   dermal fibroblasts using a non-integration system.";
RL   Stem Cell Res. 21:13-15(2017).
//
RX   PubMed=31841972; DOI=10.1016/j.scr.2019.101676;
RA   Kim Y.-K., Yu J.H., Min S.-H., Park S.-W.;
RT   "Generation of a GLA knock-out human-induced pluripotent stem cell
RT   line, KSBCi002-A-1, using CRISPR/Cas9.";
RL   Stem Cell Res. 42:101676-101676(2020).
//
RX   PubMed=33714852; DOI=10.1016/j.scr.2021.102270;
RA   Kim J.-H., Jo H.-Y., Ha H.-Y., Kim Y.-O.;
RT   "Korea National Stem Cell Bank.";
RL   Stem Cell Res. 53:102270-102270(2021).
//